right-img

Home | ANI Pharmaceuticals, Inc. (ANIP) Given Consensus Recommendation of “Hold” by Analysts

ANI Pharmaceuticals, Inc. (ANIP) Given Consensus Recommendation of “Hold” by Analysts

April 04, 2018
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) has earned an average rating of “Hold” from the seven ratings firms that are presently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have given a buy recommendation to the company. The average 1 year price […]
Read more at:https://www.americanbankingnews.com/2018/04/04/ani-pharmaceuticals-inc-anip-given-consensus-recommendation-of-hold-by-analysts.html

Site Created by finaceandbankingnewsnow.com